Donor Acute Kidney Injury and Outcomes After Deceased Donor Kidney Transplantation: A 50‐Case Single‐Center Study From Japan
Clinical Transplantation · 2026-06 · 40 (6)
DOI: 10.1111/ctr.70581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 28.05.2026. Verfasst von Yuki Nakamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Acute Kidney Injury, Tissue Donors, Delayed Graft Function. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
Elevated terminal donor creatinine often leads to kidney discard, although donor acute kidney injury (AKI) may represent reversible tubular injury. We evaluated the impact of donor AKI stage on delayed graft function (DGF), early graft recovery, and long‐term graft survival in a Japanese deceased‐donor kidney transplantation cohort.
Methods
We retrospectively analyzed 50 consecutive deceased‐donor kidney transplants performed between 2010 and 2025. Donor AKI was classified according to the Kidney Disease: Improving Global Outcomes creatinine criteria. KDPI was calculated using the OPTN refit KDRI model (October 2024 implementation). DGF was defined as dialysis requirement within 7 days after transplantation. Death‐censored graft survival was analyzed using the Kaplan–Meier method, and Cox proportional hazards modeling was performed as a univariate analysis due to the limited number of events.
Results
DGF occurred in 38 patients (76%). Higher donor AKI stage correlated significantly with DGF occurrence ( ρ = 0.372, p = 0.009), dialysis session count ( ρ = 0.316, p = 0.027), and lower eGFR at 3 months ( ρ =− 0.472, p < 0.001) and 6 months ( ρ = − 0.408, p = 0.004). During a median follow‐up of 75 months, four graft losses occurred. Death‐censored graft survival did not differ between AKI stage 0 and stages 1–3 (log‐rank p = 0.90). Five‐ and 10‐year survival rates were 95.8% and 91.2%, respectively.
Conclusions
Donor AKI was associated with increased early graft morbidity but not with inferior long‐term graft survival. Elevated terminal creatinine alone should not automatically preclude kidney utilization, particularly when reversible tubular injury is suspected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan.
- Okinaka Memorial Institute For Medical Research, Toranomon Hospital, Tokyo, Japan.
- Department of Surgery, Nephrology Center, Toranomon Hospital, Tokyo, Japan.
- Department of Clinical Engineering, Toranomon Hospital Kajigaya, Kanagawa, Japan.
- Department of Clinical Engineering, Toranomon Hospital, Tokyo, Japan.
- Department of Nephrology and Rheumatology, Nephrology Center, Toranomon Hospital, Tokyo, Japan.
ORCID-Profile: Yuki Nakamura
Zitieren
APA
Nakamura, Y., Yokoyama, T., Miki, K., Fukuda, M., Mishima, Y., Tanaka, K., Tanaka, K., Kamiyama, M., Ubara, Y., Sawa, N., & Ishii, Y. (2026). Donor Acute Kidney Injury and Outcomes After Deceased Donor Kidney Transplantation: A 50‐Case Single‐Center Study From Japan. Clinical Transplantation, 40(6). https://doi.org/10.1111/ctr.70581
Vancouver
Nakamura Y, Yokoyama T, Miki K, Fukuda M, Mishima Y, Tanaka K, et al. Donor Acute Kidney Injury and Outcomes After Deceased Donor Kidney Transplantation: A 50‐Case Single‐Center Study From Japan. Clinical Transplantation. 2026;40(6). doi:10.1111/ctr.70581
BibTeX
@article{Nakamura2026,
author = {Nakamura, Yuki and Yokoyama, Takayoshi and Miki, Katsuyuki and Fukuda, Miruzato and Mishima, Yusuke and Tanaka, Koji and Tanaka, Kiho and Kamiyama, Manabu and Ubara, Yoshifumi and Sawa, Naoki and Ishii, Yasuo},
title = {Donor Acute Kidney Injury and Outcomes After Deceased Donor Kidney Transplantation: A 50‐Case Single‐Center Study From Japan},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {6},
doi = {10.1111/ctr.70581}
}
EUVIMED